X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,557 | 0 | 0 | 0 | 3,000 |
| Cost of Goods | 797 | 0 | 0 | N/A | N/A |
| Gross Profit | 1,760 | N/A | N/A | N/A | 3,000 |
| Operating Expenses | 38,958 | 107,522 | 87,569 | 85,107 | 62,874 |
| Operating Income | -36,401 | -107,522 | -87,569 | -85,107 | -59,874 |
| Interest Expense | 8,768 | 5,777 | 3,993 | 3,642 | 2,688 |
| Other Income | 8,029 | 12,210 | -2,277 | 70 | 579 |
| Pre-tax Income | -37,140 | -101,089 | -93,839 | -88,679 | -61,983 |
| Income Tax | 310 | 78 | 28 | 17 | 148 |
| Net Income Continuous | -37,450 | -101,167 | -93,867 | -88,696 | -62,131 |
| Net Income | $-37,450 | $-101,167 | $-93,867 | $-88,696 | $-62,131 |
| EPS Basic Total Ops | -5.71 | -17.12 | -45.65 | -119.82 | -92.79 |
| EPS Basic Continuous Ops | -5.59 | -17.09 | -44.37 | -103.44 | -92.93 |
| EPS Diluted Total Ops | -5.71 | -17.12 | -45.65 | -119.82 | -92.79 |
| EPS Diluted Continuous Ops | -5.59 | -17.09 | -44.37 | -103.44 | -92.93 |
| EPS Diluted Before Non-Recurring Items | -21.32 | -17.12 | -45.65 | -119.82 | -92.79 |
| EBITDA(a) | $-35,605 | $-107,103 | $-87,056 | $-74,850 | $-59,523 |